Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Leveraging genomic large language models to enhance causal genotype-brain-clinical pathways in Alzheimer's disease

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease

Deep learning methods improve polygenic risk analysis and prediction for Alzheimer’s disease

Deep learning-based polygenic risk analysis for Alzheimer's disease prediction

Deep Learning-Based Polygenic Risk Analysis for Alzheimer’s Disease Prediction

Gene-associated Disease Discovery Powered by Large Language Models

A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease

Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

Leveraging Large Language Models for Identifying Interpretable Linguistic Markers and Enhancing Alzheimer's Disease Diagnostics

Genome-wide prediction and integrative functional characterization of Alzheimer’s disease-associated genes

Systems genetic dissection of Alzheimer's disease brain gene expression networks

Functional molecular network models for the genetic risk factors of Alzheimer’s disease: Genetics/omics and systems biology

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Multi-class Modeling Identifies Shared Genetic Risk for Late-onset Epilepsy and Alzheimer's Disease

Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum

Large Language Models Assisted Multi-Effect Variants Mining on Cerebral Cavernous Malformation Familial Whole Genome Sequencing

Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis

Functional characterization of Alzheimer's disease genetic variants in microglia

Discovery of Genetic Biomarkers for Alzheimer's Disease Using Adaptive Convolutional Neural Networks Ensemble and Genome-Wide Association Studies

Genetic Discovery Enabled by A Large Language Model